04 Malignant Skin Lesions

J clin oncol 17976 1999 45 sim fh taylor wf pritchard

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: factors. Cancer Control 12:223, 2005 34. Balch CM, Soong SJ, Gershenwald JE, et al: Prognostic factors analysis of 17,600 melanoma 44. Gershenwald JE, Thompson W, Mansfield PF, et al: Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 17:976, 1999 45. Sim FH, Taylor WF, Pritchard DJ, et al: Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc 61:697, 1986 46. Veronesi U, Adamus J, Bandiera DC, et al: Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 49:2420, 1982 47. Cascinelli N, Morabito A, Santinami M, et al: Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial. WHO Melanoma Programme. Lancet © 2006 WebMD, Inc. All rights reserved. ACS Surgery: Principles and Practice 3 BREAST, SKIN, AND SOFT TISSUE 351:793, 1998 4 Malignant Skin Lesions — 12 patients with multiple in-transit metastases. Ann Surg 240:939, 2004 48. Balch DM, Soong S, Ross MI, et al: Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 7:87, 2000 62. Feldman AL, Alexander HR Jr, Bartlett DL, et al: Management of extremity recurrences after complete responses to isolated limb perfusion in patients with melanoma. Ann Surg Oncol 6:562, 1999 49. McMasters KM, Reintgen DS, Ross MI, et al: Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol 19:2851, 2001 63. Stevens G, Thompson JF, Firth I, et al: Locally advanced melanoma: results of postoperative hypofractionated radiation therapy. Cancer 88:88, 2000 50. Morton D, Thompson JF, Cochran AJ: Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I: an international multicenter trial. Ann Surg 242:302, 2005 64. Ang KK, Byers RM, Peters LJ, et al: Regional radiotherapy as adjuvant treatment for head and neck malignant melanoma. Arch Otolaryngol Head Neck Surg 116:169, 1990 51. Morton DL: Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I) in clinical stage I melanoma. http://www.asco.org/ac/1,1003,_12-00251100_18-0034-00_19-003013,00.asp, accessed July 31, 2006 65. Morris KT, Marquez CM, Holland JM, et al: Prevention of local recurrence after surgical debulking of nodal and subcutaneous melanoma deposits by hypofractionated radiation. Ann Surg Oncol 7:680, 2000 52. Thomas JM: Time for comprehensive reporting of MSLT-1. Lancet Oncol 7:9, 2006 53. Clinical Practice Guidelines for the Management of Cutaneous Melanoma. National Health and Medical Research Council, Canberra, 1999 54. Chan AD, Essner R, Wanek LA, et al: Judging the therapeutic value of lymph node dissections for melanoma. J Am Coll Surg 191:16, 2000 55. Morton...
View Full Document

This note was uploaded on 03/21/2011 for the course ONC 01 taught by Professor Dzodic during the Spring '11 term at Multimedia University, Cyberjaya.

Ask a homework question - tutors are online